Kit Mutations New Insights and Diagnostic Value

被引：14

作者：

Falchi, Lorenzo ^{[1
]}

Verstovsek, Srdan ^{[2
]}

机构：

[1] Columbia Univ, Div Hematol Oncol, Med Ctr, 177 Ft Washington Ave,MHB 6GN-435, New York, NY 10032 USA

[2] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, 1515 Holcombe Blvd,Unit 428, Houston, TX 77030 USA

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2018年 / 38卷 / 03期

关键词：

KIT mutations; KIT D816V; Cutaneous mastocytosis; Systemic mastocytosis; Imatinib; Midostaurin; Avapritinib; ACUTE MYELOID-LEUKEMIA; PROTOONCOGENE C-KIT; MAST-CELL DISORDERS; TYROSINE KINASE INHIBITOR; POLYMERASE-CHAIN-REACTION; SYSTEMIC MASTOCYTOSIS SM; D816V MUTATION; CUTANEOUS MASTOCYTOSIS; IMATINIB MESYLATE; WILD-TYPE;

D O I：

10.1016/j.iac.2018.04.005

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Mastocytosis is a World Health Organization-defined clonal mast cell disorder characterized by significant clinicopathologic heterogeneity. Despite this diversity, a mutation of the KIT gene, most commonly D816V, is found in almost all cases and believed to be a driver lesion. Peripheral blood allele-specific oligonucleotide polymerase chain reaction can reliably detect KIT D816V and is used for the initial screening of adults with suspected systemic mastocytosis. The discovery of KIT mutations as central to the pathobiology of mastocytosis has prompted development of KIT-targeted agents, including imatinib and midostaurin (approved medications for patients with advanced systemic mastocytosis), and drugs in development, such as KIT D816V-specific inhibitor avapritinib.

引用

收藏

页码：411 / +

页数：19

相关论文

共 112 条

[1] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].

Akin, C ;

Fumo, G ;

Yavuz, AS ;

Lipsky, PE ;

Neckers, L ;

Metcalfe, DD .

BLOOD, 2004, 103 (08) :3222-3225

[2] Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis [J].

Akin, C ;

Kirshenbaum, AS ;

Semere, T ;

Worobec, AS ;

Scott, LM ;

Metcalfe, DD .

EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :140-147

[3] Molecular diagnosis of mast cell disorders - A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology [J].

Akin, Cem .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (04) :412-419

[4] Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis [J].

Alvarez-Twose, I. ;

Vano-Galvan, S. ;

Sanchez-Munoz, L. ;

Morgado, J. M. ;

Matito, A. ;

Torrelo, A. ;

Jaen, P. ;

Schwartz, L. B. ;

Orfao, A. ;

Escribano, L. .

ALLERGY, 2012, 67 (06) :813-821

[5] Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis [J].

Alvarez-Twose, Ivan ;

Gonzalez, Pablo .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :E126-E129

[6]

[Anonymous], 2017, BLOOD S1

[7]

[Anonymous], 2017, WHO CLASSIFICATION T

[8] KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis [J].

Arock, M. ;

Sotlar, K. ;

Akin, C. ;

Broesby-Olsen, S. ;

Hoermann, G. ;

Escribano, L. ;

Kristensen, T. K. ;

Kluin-Nelemans, H. C. ;

Hermine, O. ;

Dubreuil, P. ;

Sperr, W. R. ;

Hartmann, K. ;

Gotlib, J. ;

Cross, N. C. P. ;

Haferlach, T. ;

Garcia-Montero, A. ;

Orfao, A. ;

Schwaab, J. ;

Triggiani, M. ;

Horny, H-P ;

Metcalfe, D. D. ;

Reiter, A. ;

Valent, P. .

LEUKEMIA, 2015, 29 (06) :1223-1232

[9] Stem cell factor-mediated wild-type KIT receptor activation is critical for gastrointestinal stromal tumor cell growth [J].

Bai, Chen-Guang ;

Hou, Xiao-Wei ;

Wang, Feng ;

Qiu, Cen ;

Zhu, Yan ;

Huang, Ling ;

Zhao, Jing ;

Xu, Jing-Jing ;

Ma, Da-Lie .

WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (23) :2929-2937

[10] Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation [J].

Bai, Y. ;

Bandara, G. ;

Chan, E. Ching ;

Maric, I. ;

Simakova, O. ;

Bandara, S. N. ;

Lu, W-P ;

Wise, S. C. ;

Flynn, D. L. ;

Metcalfe, D. D. ;

Gilfillan, A. M. ;

Wilson, T. M. .

LEUKEMIA, 2013, 27 (02) :278-285

← 1 2 3 4 5 6 7 8 9 10 →